Rudi Mariën is a Belgian scientist and businessman. He is Chairman of the Belgian biotech company Innogenetics.
Rudi Mariën obtained a degree in pharmaceutical sciences from the University of Ghent, and specialized in clinical biology.
On 18 July 1985, he co-founded the Belgian biotech company Innogenetics, together with Erik Tambuyzer and Hugo Van Heuverswyn and has been its Chairman since then. Besides Innogenetics, he founded several clinical laboratories. He is at present managing director of BARC NV, an international centralized clinical laboratory. He is also CEO of Gengest BVBA (management company), Biovest CVA, LMA BVBA, Laboraco BVBA, and he is director of DSJ Bruxelles NV and Oystershell NV. Rudi Mariën is a member of the American Association for Clinical Chemistry.